Disclosures for "Emergent Carotid Endarterectomy Is Associated with Good 3-month Clinical Outcomes and Low 3-month Mortality in Patients with Acute Ischemic Stroke and Acute Cervical Internal Carotid Artery Occlusion"
-
Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Roman Herzig, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Care Comm.
-
Dr. Gunka has nothing to disclose.
-
Dr. Ostry has nothing to disclose.
-
Dr. Fiedler has nothing to disclose.
-
Dr. Priban has nothing to disclose.
-
The institution of Dr. Kovar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PHRI. Dr. Kovar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Kovar has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Kovar has received research support from StroCzech Research Network.
-
Prof. Stadler has received publishing royalties from a publication relating to health care.
-
Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Meditorial.
-
Mr. Neumann has received personal compensation for serving as an employee of Boehringer Ingelheim. Mr. Neumann has received personal compensation for serving as an employee of Teva. Mr. Neumann has received personal compensation for serving as an employee of Novartis. Mr. Neumann has received personal compensation for serving as an employee of Pfizer.
-
Dr. Kunesova has nothing to disclose.